Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivoGuoshun Luo, Hua Xiang, Xin Lin et al.|Acta Pharmaceutica Sinica B|2020Cited by 77
Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted DegradationGuoshun Luo, Hua Xiang, Carlos A. Velázquez‐Martínez et al.|Journal of Medicinal Chemistry|2021Cited by 49
Discovery of novel 2H-chromene-3-carbonyl derivatives as selective estrogen receptor degraders (SERDs): Design, synthesis and biological evaluationXiang Lu, Hua Xiang, Xinglong Chi et al.|Bioorganic Chemistry|2021Cited by 12
Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulatorGuoshun Luo, Hua Xiang, Zhenbang Li et al.|European Journal of Medicinal Chemistry|2020Cited by 9